Monday, September 4, 2023

Ozempic-maker Novo Nordisk becomes Europe's most valuable company / Hollywood loses 17,000 jobs / Walmart increases Flipkart stake

Plus: the FTC approves Amgen's $27.8B bid for Horizon Therapeutics